AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
Archives: News
Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing
Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce their strategic partnership, aimed at revolutionizing the biopharma industry. By leveraging Partex’s proprietary AI (Artificial Intelligence) technology and Anavex’s innovative precision medicine drug development platform, we seek to enhance patient outcomes and reshape the …
AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary medical exchange, there are so-called tumor boards, in which the physicians discuss the treatment strategy. For this purpose, a large amount of medical data is available for each individual patient, which must be evaluated individually …
OncoCoin AG donates for a charity bicycle tour: Tour of Hope
Bad Hersfeld / Germany, Aug 02, 2022– Mayor Thomas Fehling took the opportunity at the Smart City Forum, which took place a few days ago in the Bad Hersfeld Stadthalle, to meet with the Chief Marketing Officer Claudia M. Hausoel at the booth of Innoplexus AG / OncoCoin AG. The pleasant occasion: Fehling expressed his …
OncoCoin AG donates for a charity bicycle tour: Tour of Hope Read More »
Innoplexus and Innovatrix capital partner to bring about new risk-transfer solutions for the life science industry
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning (ML) to bring about new risk-transfer solutions for the life science industry. Eschborn, Germany/London, U.K., 27 July 2022Innoplexus AG is pleased to announce that an agreement for a strategic partnership with Innovatrix Capital Ltd. has …
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30, 2022 – Innoplexus, a global leader in AI-based drug discovery and development, and Inflection Biosciences Ltd., an innovative biotechnology company focused upon developing innovative small molecule therapeutics for the treatment of cancer, autoimmune and …
Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform
COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19. ESCHBORN, Germany, Boston, M.A. and Durham, N.C., May 11, 2021 – Innoplexus, a global leader in AI-based drug discovery and development, and Parexel, a leading global clinical research organization, have expanded the features and functionality of their COVID-19 Clearinghouse platform …
Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform Read More »
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic
COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and ESCHBORN, Germany, Sept. 24, 2020 (GLOBE NEWSWIRE) — Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through Commercialization, in collaboration …
Wie das „Google der Pharmaindustrie“ den Kampf gegen Corona gewinnen will
Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz beim Kampf gegen Covid-19 und Krebs helfen kann. Eine Prognose, wann ein wirksames Mittel auf den Markt kommen kann, wagt er nicht. Beim Börsengang sieht das aber schon anders aus. WELT: Herr Bhardwaj, Ihr Unternehmen Innoplexus …
Wie das „Google der Pharmaindustrie“ den Kampf gegen Corona gewinnen will Read More »
Der Pharma-Visionär
Mit künstlicher Intelligenz gegen Krankheiten: Wie Gunjan Bhardwaj die Regeln der Arzneimittelforschung umschreiben will – für schnellere Ergebnisse und bessere Medikamente. Der Rollkoffer steht schon bereit. Ein kleiner, schwarzer Trolley, für einen Kurztrip – nach Indien, der Heimat von Gunjan Bhardwaj. Bevor es losgeht, erzählt der „indische Schwabe“ (so nennt er sich) aber noch, wie …